Page 16 - Kate Elder News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Covid-19 pandemic Friday 8 January 2021, by Sharon Lerner Pfizer CEO Albert Bourla recently heaped praise on “the almost 44,000 people who selflessly raised their hands to participate in our trial.” “Each of you has helped to bring the world one step closer to our shared goal of a potential vaccine to fight this devastating pandemic,” Bourla wrote in an open letter to volunteers who took part in Pfizer’s Covid-19 vaccine research, which was conducted in Argentina, South Africa, Brazil, Germany, and Turkey as well as the U.S. His letter was published on November 9, the same day Pfiz...

Boxes containing the Moderna Covid-19 vaccine are prepared to be shipped at the McKesson distribution center in Olive Branch on Dec. 20, 2020 in Olive Branch, Miss.Photo: Paul Sancya/Pool/Getty ImagesBoxes containing the Moderna Covid-19 vaccine are prepared to be shipped at the McKesson distribution center in Olive Branch on Dec. 20, 2020 in Olive Branch, Miss.Photo: Paul Sancya/Pool/Getty Images World Faces Covid-19 “Vaccine Apartheid” Even countries that hosted vaccine trials — like Argentina, South Africa, Brazil, and Turkey — will not receive adequate supplies. Decemb...

“Even with the unprecedented levels of public financing and the accelerated pace of bringing such vaccines to market, global demand will vastly outstrip available supply during this scale-up period. Intense interest has focused on which countries and when populations will have access to safe and effective vaccine candidates emerging from research and development,” the Johns Hopkins University researchers said in their study. Higher income countries, including the European Union bloc, have secured deals to purchase 51% of vaccine doses although they only make up less than 14% of the world�...

Print this page Nearly two billion doses of COVID-19 vaccines have been secured for equitable distribution in 2021 to the 190 countries that have signed on to a World Health Organization-led partnership, according to a Friday announcement from the group.  Officials from the vaccine manufacturers said they expect delivery to begin in the first quarter of next year.  The partnership, known as COVAX, said the supply includes at least 1.3 billion doses for low- and middle-income countries.  With the first vaccine beginning to arrive in some high-income countries and a second nearing appr...

Print this page While the first shots against COVID-19 are rolling out in the United States, Britain and Canada, nearly a quarter of the world's population likely will not have access to a vaccine until at least 2022, according to a new study.  Even in a best-case scenario, the world does not have the manufacturing capacity to cover the entire global population.   Wealthier countries made deals to buy the bulk of vaccine doses before the shots have even finished testing or received regulatory approval.   Meanwhile, a partnership aimed at securing vaccines for low- and middle-income c...